ID   ANM2_MOUSE              Reviewed;         448 AA.
AC   Q9R144;
DT   11-JAN-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   07-APR-2021, entry version 120.
DE   RecName: Full=Protein arginine N-methyltransferase 2;
DE            EC=2.1.1.319 {ECO:0000250|UniProtKB:P55345};
DE   AltName: Full=Histone-arginine N-methyltransferase PRMT2;
GN   Name=Prmt2; Synonyms=Hrmt1l1;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Tsyba L.O., Kvasha S.M., Skripkina I.Y., Anoprienko O.V., Slavov D.,
RA   Tassone F., Rynditch A.V., Gardiner K.;
RL   Submitted (JUL-1999) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   FUNCTION, INTERACTION WITH RB1 AND E2F1, AND TISSUE SPECIFICITY.
RX   PubMed=16616919; DOI=10.1016/j.yexcr.2006.03.001;
RA   Yoshimoto T., Boehm M., Olive M., Crook M.F., San H., Langenickel T.,
RA   Nabel E.G.;
RT   "The arginine methyltransferase PRMT2 binds RB and regulates E2F
RT   function.";
RL   Exp. Cell Res. 312:2040-2053(2006).
RN   [3]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=16648481; DOI=10.1128/mcb.26.10.3864-3874.2006;
RA   Ganesh L., Yoshimoto T., Moorthy N.C., Akahata W., Boehm M., Nabel E.G.,
RA   Nabel G.J.;
RT   "Protein methyltransferase 2 inhibits NF-kappaB function and promotes
RT   apoptosis.";
RL   Mol. Cell. Biol. 26:3864-3874(2006).
RN   [4]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=20798359; DOI=10.1161/circresaha.110.225326;
RA   Iwasaki H., Kovacic J.C., Olive M., Beers J.K., Yoshimoto T., Crook M.F.,
RA   Tonelli L.H., Nabel E.G.;
RT   "Disruption of protein arginine N-methyltransferase 2 regulates leptin
RT   signaling and produces leanness in vivo through loss of STAT3
RT   methylation.";
RL   Circ. Res. 107:992-1001(2010).
RN   [5]
RP   FUNCTION.
RX   PubMed=20708585; DOI=10.1016/j.devcel.2010.07.007;
RA   Blythe S.A., Cha S.-W., Tadjuidje E., Heasman J., Klein P.S.;
RT   "beta-Catenin primes organizer gene expression by recruiting a histone H3
RT   arginine 8 methyltransferase, Prmt2.";
RL   Dev. Cell 19:220-231(2010).
CC   -!- FUNCTION: Arginine methyltransferase that methylates the guanidino
CC       nitrogens of arginyl residues in proteins such as STAT3, FBL, histone
CC       H4. May inhibit NF-kappa-B transcription, and promote apoptosis.
CC       Represses E2F1 transcriptional activity (in a RB1-dependent manner).
CC       Has a negative regulation effect on G1 to S transition of mitotic cell
CC       cycle. Involved in growth regulation. Acts as a coactivator (with
CC       NCOA2) of the androgen receptor (AR)-mediated transactivation. Acts as
CC       a coactivator (with estrogen) of estrogen receptor (ER)-mediated
CC       transactivation. Enhances PGR, PPARG, RARA-mediated transactivation.
CC       {ECO:0000269|PubMed:16616919, ECO:0000269|PubMed:16648481,
CC       ECO:0000269|PubMed:20708585, ECO:0000269|PubMed:20798359}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-arginyl-[protein] + 2 S-adenosyl-L-methionine = 2 H(+) +
CC         N(omega),N(omega)-dimethyl-L-arginyl-[protein] + 2 S-adenosyl-L-
CC         homocysteine; Xref=Rhea:RHEA:48096, Rhea:RHEA-COMP:10532, Rhea:RHEA-
CC         COMP:11991, ChEBI:CHEBI:15378, ChEBI:CHEBI:29965, ChEBI:CHEBI:57856,
CC         ChEBI:CHEBI:59789, ChEBI:CHEBI:61897; EC=2.1.1.319;
CC         Evidence={ECO:0000250|UniProtKB:P55345};
CC   -!- SUBUNIT: Self-associates (By similarity). Interacts with HNRNPUL1.
CC       Interacts with NFKBIA (By similarity). Interacts with NCOA6
CC       coactivator. Interacts (via SH3 domain) with PRMT8. Interacts with AR.
CC       Interacts with ESR1, ESR2, PGR, PPARG, RARA, RXRA and THRB (By
CC       similarity). Interacts with RB1 and E2F1. {ECO:0000250,
CC       ECO:0000269|PubMed:16616919}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Nucleus {ECO:0000250}.
CC       Note=Translocates from the cytoplasm to the nucleus, after hormone
CC       exposure. {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Expressed in liver, pancreas, lung, brain, skeletal
CC       muscle, heart, muscle and fat. {ECO:0000269|PubMed:16616919}.
CC   -!- DISRUPTION PHENOTYPE: From 6 to 30 weeks of age, males gain less weight
CC       than age-matched control wild-type mice when weaned onto a chow diet.
CC       By 30 weeks of age, females are also lean compared with wild-type
CC       females. At 12 weeks of age, male and female are 3% to 4% shorter than
CC       wild-type controls. Shows less hepatic cytoplasmic vacuoles, more
CC       distinct hepatic cords and sinusoids and increased leptin sensitivity.
CC       {ECO:0000269|PubMed:16648481, ECO:0000269|PubMed:20798359}.
CC   -!- SIMILARITY: Belongs to the class I-like SAM-binding methyltransferase
CC       superfamily. Protein arginine N-methyltransferase family.
CC       {ECO:0000255|PROSITE-ProRule:PRU01015}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF169620; AAD48847.1; -; mRNA.
DR   SMR; Q9R144; -.
DR   IntAct; Q9R144; 1.
DR   iPTMnet; Q9R144; -.
DR   PhosphoSitePlus; Q9R144; -.
DR   PaxDb; Q9R144; -.
DR   PRIDE; Q9R144; -.
DR   ProteomicsDB; 296251; -.
DR   MGI; MGI:1316652; Prmt2.
DR   InParanoid; Q9R144; -.
DR   PhylomeDB; Q9R144; -.
DR   ChiTaRS; Prmt2; mouse.
DR   PRO; PR:Q9R144; -.
DR   Proteomes; UP000000589; Unplaced.
DR   RNAct; Q9R144; protein.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005829; C:cytosol; ISS:BHF-UCL.
DR   GO; GO:0005654; C:nucleoplasm; ISO:MGI.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0050681; F:androgen receptor binding; ISS:BHF-UCL.
DR   GO; GO:0008013; F:beta-catenin binding; IPI:UniProtKB.
DR   GO; GO:0030331; F:estrogen receptor binding; ISS:UniProtKB.
DR   GO; GO:0042054; F:histone methyltransferase activity; ISS:UniProtKB.
DR   GO; GO:0008469; F:histone-arginine N-methyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0042975; F:peroxisome proliferator activated receptor binding; ISS:BHF-UCL.
DR   GO; GO:0033142; F:progesterone receptor binding; ISS:BHF-UCL.
DR   GO; GO:0042803; F:protein homodimerization activity; ISS:BHF-UCL.
DR   GO; GO:0016274; F:protein-arginine N-methyltransferase activity; IMP:UniProtKB.
DR   GO; GO:0035242; F:protein-arginine omega-N asymmetric methyltransferase activity; IEA:UniProtKB-EC.
DR   GO; GO:0044877; F:protein-containing complex binding; IPI:UniProtKB.
DR   GO; GO:0042974; F:retinoic acid receptor binding; ISS:BHF-UCL.
DR   GO; GO:0046966; F:thyroid hormone receptor binding; ISS:BHF-UCL.
DR   GO; GO:0003713; F:transcription coactivator activity; ISO:MGI.
DR   GO; GO:0048588; P:developmental cell growth; IMP:UniProtKB.
DR   GO; GO:0016571; P:histone methylation; IDA:UniProtKB.
DR   GO; GO:0033210; P:leptin-mediated signaling pathway; NAS:BHF-UCL.
DR   GO; GO:0032259; P:methylation; NAS:BHF-UCL.
DR   GO; GO:0043433; P:negative regulation of DNA-binding transcription factor activity; IMP:UniProtKB.
DR   GO; GO:2000134; P:negative regulation of G1/S transition of mitotic cell cycle; IMP:UniProtKB.
DR   GO; GO:0032088; P:negative regulation of NF-kappaB transcription factor activity; ISO:MGI.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; ISS:UniProtKB.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; ISS:UniProtKB.
DR   GO; GO:0060765; P:regulation of androgen receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0042509; P:regulation of tyrosine phosphorylation of STAT protein; NAS:BHF-UCL.
DR   GO; GO:0001666; P:response to hypoxia; IDA:BHF-UCL.
DR   InterPro; IPR025799; Arg_MeTrfase.
DR   InterPro; IPR029063; SAM-dependent_MTases.
DR   InterPro; IPR036028; SH3-like_dom_sf.
DR   InterPro; IPR001452; SH3_domain.
DR   InterPro; IPR007848; Small_mtfrase_dom.
DR   Pfam; PF05175; MTS; 1.
DR   Pfam; PF00018; SH3_1; 1.
DR   PRINTS; PR00452; SH3DOMAIN.
DR   SMART; SM00326; SH3; 1.
DR   SUPFAM; SSF50044; SSF50044; 1.
DR   SUPFAM; SSF53335; SSF53335; 1.
DR   PROSITE; PS51678; SAM_MT_PRMT; 1.
DR   PROSITE; PS50002; SH3; 1.
PE   1: Evidence at protein level;
KW   Cytoplasm; Methylation; Methyltransferase; Nucleus; Reference proteome;
KW   S-adenosyl-L-methionine; SH3 domain; Transferase.
FT   CHAIN           1..448
FT                   /note="Protein arginine N-methyltransferase 2"
FT                   /id="PRO_0000212325"
FT   DOMAIN          42..101
FT                   /note="SH3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00192"
FT   DOMAIN          111..414
FT                   /note="SAM-dependent MTase PRMT-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01015"
FT   REGION          1..289
FT                   /note="Interaction with ESR1"
FT                   /evidence="ECO:0000250"
FT   REGION          95..219
FT                   /note="Interaction with RB1"
FT                   /evidence="ECO:0000269|PubMed:16616919"
FT   REGION          145..287
FT                   /note="Interaction with ESR1"
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        223
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        232
FT                   /evidence="ECO:0000250"
FT   BINDING         124
FT                   /note="S-adenosyl-L-methionine"
FT                   /evidence="ECO:0000250"
FT   BINDING         133
FT                   /note="S-adenosyl-L-methionine"
FT                   /evidence="ECO:0000250"
FT   BINDING         157
FT                   /note="S-adenosyl-L-methionine; via carbonyl oxygen"
FT                   /evidence="ECO:0000250"
FT   BINDING         180
FT                   /note="S-adenosyl-L-methionine"
FT                   /evidence="ECO:0000250"
FT   BINDING         209
FT                   /note="S-adenosyl-L-methionine"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         73
FT                   /note="Asymmetric dimethylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:P55345"
FT   MOD_RES         84
FT                   /note="Asymmetric dimethylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:P55345"
SQ   SEQUENCE   448 AA;  50476 MW;  63E1F8C3FC66C25E CRC64;
     MEAPGEGPCS ESQVIPVLEE DPVDYGCEMQ LLQDGAQLQL QLQPEEFVAI ADYTATDETQ
     LSFLRGEKIL ILRQTTADWW WGERAGCCGY IPANHLGKQL EEYDPEDTWQ DEEYFDSYGT
     LKLHLEMLAD QPRTTKYHSV ILQNKESLKD KVILDVGCGT GIISLFCAHH ARPKAVYAVE
     ASDMAQHTSQ LVLQNGFADT ITVFQQKVED VVLPEKVDVL VSEWMGTCLL FEFMIESILY
     ARDTWLKGDG IIWPTTAALH LVPCSAEKDY HSKVLFWDNA YEFNLSALKS LAIKEFFSRP
     KSNHILKPED CLSEPCTILQ LDMRTVQVPD LETMRGELRF DIQKAGTLHG FTAWFSVYFQ
     SLEEGQPQQV VSTGPLHPTT HWKQTLFMMD DPVPVHTGDV VHGFCCVTKK SGMEKAHVCL
     SELGCHVRTR SHVSTELETG SFRSGGDS
//
